Skip links

Digitized, Digitalized and Transformed: Still Lagging Behind?

Jump To Section

A practical approach for IT modernization

In a recent study by Harvard Business Review, a notable 89% of global companies embracing digital and AI transformation reported a 31% increase in expected revenue and 25% in cost savings. The banking sector’s success, with digital leaders achieving an 8.1% annual total shareholder return compared to 4.9%, highlights the significance of revenue growth and expense control.

Background: Evolution of aging platforms

The digitization of assets and process automation, initiated in the ’90s, has evolved in response to changing business conditions and innovation, especially in sectors like banking, healthcare, and insurance. Unfortunately, this evolution has led to the development of complex and outdated platforms.

Identifying challenges

Reviewing various efforts in transformation and modernization, the top five reasons for setbacks become apparent even within large institutions. Despite successful transformations fostering digital business, these challenges persist, often overlooked but undeniably real in sizable organizations.

  • Lack of holistic approach: Rushing into specific areas without considering the big picture.
  • Inadequate evaluation of current platform state: Neglecting factors like traffic patterns, maintainability, and usage. Right sizing and modeling are critical.
  • Incorrect technology choices: Influenced by internal/external factors or incorrect information.
  • Short-term focus: Prioritizing quick gains without considering negative side effects.
  • Resistance to change: Allowing applications to grow to a state where change becomes undesirable.

Notably, this list excludes non-starters such as lack of business priority, funding issues, poor execution, and team skill deficits.

Doing it right: A Blueprint

While every case is unique, our experience has shown that adhering to certain guidelines is crucial:

  1. Methodical approach: Deeply evaluate business and technology.
  2. Comprehensive evaluation: Leave no element unexplored; avoid shortcuts.
  3. Reality check: Go beyond documentation; understand the actual system’s current state.
  4. Long-term perspective: Challenge deviations impacting timelines, costs, or outcomes.
  5. Holistic approach: Avoid piecemeal strategies; understand the entire system.
  6. Informed choices: Compare multiple options for technology decisions; enforce criteria.
  7. Adaptive design: Demonstrate architectural patterns that counter “too big to fail” concerns.
  8. Right sizing: Tailor services appropriately; even a monolith can be a valid choice.
  9. Proven accelerators: Utilize and customize industry-proven accelerators.
  10. Automation: Implement full automation at every stage, from infrastructure to deployment.
  11. Security first: Define security and compliance from the outset.

Digital Business Methodology – A practitioner’s mantra

Success requires a methodical approach. Our DBM (Digital Business Methodology) provides insight into the “What” that shapes your approach, with the “How” contingent on tools, ecosystem, leadership support, and team skill set.

The primary objective is to uncover authentic context and challenges during this 4 to 12-week phase, depending on the size of the platform and team dynamics.

  • Conduct brainstorming sessions involving both business and technology teams.
  • Assess current state maturity, ecosystem optimization, infrastructure readiness, application and data assessment, backward compatibility needs, and team skill sets.
  • Define the target state, prioritizing incremental outcomes.

Lasting 1 to 6 months, this phase focuses on creating an optimized ecosystem. Specialized expertise is crucial in ensuring an accurate setup. We employ accelerators like pre-defined templates, scripts, and AI tools tailored to each platform’s unique characteristics.

Construction and deployment of authentic business features onto the modernized platform occur, with a select group of pilot users exposed to these features. While considering refinements and advanced capabilities for the ecosystem, these aspects are better addressed in Phase-2. Neglecting meticulous foundation preparation could potentially jeopardize the entire undertaking.

The focus of this phase is on achieving tangible outcomes within a reasonable two-year timeframe, instead of a potential five-year timeline.

  • Alongside achieving bite-sized goals, it is vital to assess the team’s burn-rate, considering potential business repercussions such as customer loss or missed opportunities.
  • Development practices, code generation tools, reusable logic, and common utilities play pivotal roles in expediting the transformation process.


Transformation setbacks provide invaluable lessons that shape the path forward. Sustaining an up-to-date platform is an ongoing, dynamic process that demands constant evaluation and execution within a Digital Business organization.

The primary architectural goal for achieving a transformed state is the meticulous design of a system where elements can be upgraded and transformed independently. Success in this journey hinges on our unwavering ability to adapt continuously. As we navigate the swift evolution of technology, the critical question remains: Are we truly equipped for this transformative journey, or do we risk falling behind in the dynamic realm of innovation?

Sasikumar Kannappan

Sasikumar Kannappan

Latest Reads


Suggested Reading

Ready to Unlock Yours Enterprise's Full Potential?

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes